RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. NRG Therapeutics

NRG Therapeutics

energizing drug discovery in neurodegenerative diseases.

Latest funding

$67M Series B+ ·

Led by Dementia Discovery Fund · Source: fundraisingfox.com

Total raised: $85M across 2 sourced rounds

All 2 rounds ↓
X: @NrgTherapeutics · 76 followers.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biopharma, Biotechnology, Health Care, Neuroscience, Pharmaceutical.
Stage: Series B+.
Based in: Stevenage, United Kingdom.
Founded: 2018.
Total raised: $85M in 2 sourced rounds.
Last round: Sep 8, 2025 · 434 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

X account@NrgTherapeutics · created May 5, 2021 (5 years old) · 76 followers
Website registeredApr 3, 2018 (8 years old)
TIMELINE · MONEY RAISED

NRG Therapeutics | 553 days from X account to first raise on record

@NrgTherapeutics·Raised $85M in 2 sourced rounds·1 signal before the first raise
$21M$43M$64M$85MJUNMARDECSEPJUNMARDECSEP$85M||X ACCOUNT CREATED @NRGTHERAPEUTICS · MAY 5, 2021$18M Series A · Nov 9, 2022$18M A · NOV '22$67M Series B+ · Sep 8, 2025$67M B+ · SEP '25

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series B+$67MDDementia Discovery Fundfundraisingfox.com
Series A$18MOOmega Fundsfundraisingfox.com

Timeline

  1. X account created
  2. Website created

Founders and team

Investors

Companies like NRG Therapeutics

Other companies backed by Dementia Discovery Fund

Dementia Discovery Fund portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/nrg-therapeutics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy